Vulvar Vestibulitis Clinical Trial: Desipramine-Lidocaine

Completed · Not applicable · Has a placebo group

Conditions studied: Vulvar Disease

In brief

The Vulvar Vestibulitis Clinical Trial (VVCT) a randomized, placebo-controlled, double blinded clinical trial. We will study the clinical efficacy of four medical treatments for vulvar vestibulitis: topical lidocaine, oral desipramine, combined lidocaine and desipramine, and placebo cream and capsules. Desipramine is a tricyclic antidepressant commonly used by clinicians for treatment of several chronic pain conditions that demonstrates an optimal side effect profile compared to other tricyclic antidepressants. Topical lidocaine has also been found to be beneficial for vulvar vestibulitis treatment in small studies. It is hypothesized that the combined use of oral desipramine and topical lidocaine will be more therapeutically effective than either one by itself and better than placebo.

Key facts

Study ID
NCT00276068
Run by
University of Rochester
People needed
128
Starts
2002-08-01
Expected to finish
2007-09-01
Last updated by the study team
2007-11-14

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: accepted.

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.